🇨🇭January 1, 1970·Jan 1, 1970Industry

PBMCs for translational immune research | Lonza

Publisher

Lonza Bioscience

Switzerland

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Lonza Bioscience
Region: Switzerland
Scope: Industry
Published: January 1, 1970

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on bioscience.lonza.com

Leave the platform to read the original full article on the publisher site.

Source: Lonza Bioscience

Scope: Industry

Open original article

Related coverage

More related coverage

Eledon Pharmaceuticals/36m ago

Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus

Eledon Pharmaceuticals/37m ago

All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study

Allogene Therapeutics/4h ago

Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors